Publish Date :2017-09-13
A new study suggests that adult females who take hormone replacement therapy (HRT) to relieve menopause symptoms such as night sweats and hot flashes will be no more prone to premature death than those who don’t take hormones.
Publish Date :2017-09-11
On Monday, Novartis AG achieved a trial win for its medicine cocktail for treating skin cancer, while a competitor drug from Roche AG with dropping sales, failed in a disjointed study with an analogous patient group.
Publish Date :2017-09-06
Denmark’s Novo Nordisk will compensate around USD 58.7 million to settle claims that the drug manufacturer’s sales team understated the significance of the warnings prescribed by the United States Food and Drug Administration regarding ...
Publish Date :2017-09-06
Following huge clinical trial hindrance in lung cancer last month, the British pharma giant, AstraZeneca will look forward to restoring its reputation in oncology field next week when it brings out complete details of two major clinical tri...
Publish Date :2017-08-31
On Wednesday, Novartis AG won much awaited U.S. approval for the only of a new kind of powerful gene-altering immunotherapy for blood cancer, a treatment that worth of around USD 4.75 million, marks the beginning of a possible new treatment...
Publish Date :2017-08-31
It is suggested by a recent study, that women who have high common flame retardant concentrations in their urine might face difficulties in conceiving and carry a baby. The chemicals are known as organophosphate flame retardants also termed...
Publish Date :2017-08-30
It is suggested by a large study that the guidelines associates with global dietary must be amended to grant people less amount of carbohydrates, increase a little of the fat intake and slightly reduce the intake of fruits and vegetables....
Publish Date :2017-08-30
On Tuesday Abbott Laboratories said that they will soon come up with updates to notify patients that the batteries of the devices may drain earlier than anticipated and to decrease the hazard of its St. Jude heart implants being hacked.
Publish Date :2017-08-30
A big study revealed that a new type of medicine for cholesterol by Merck & Co Inc eliminate the risk of death and heart attack by almost 9% while inducing an upsurge of the medicine in fat tissue, resulting in the commercial future of the ...
Publish Date :2017-08-30
On Monday, the US-pharma giant Gilead Sciences approved to acquire Kite Pharma in a nearly USD 12 billion worth deal, as it ganders to swap declining sales from hepatitis C medicine with a rising and exclusive cancer immunotherapies class t...